MoneyWorks4Me

Lactose India - Quaterly Results

12 Aug 2024 Evaluate
The revenue zoomed 7.27% to Rs. 294.63 millions for the quarter ended June 2024 as compared to Rs. 274.67 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2024 zoomed to 137.10% from Rs. 9.57 millions to Rs. 22.69  millions.Operating Profit saw a handsome growth to 57.93 millions from 40.50 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 294.63 274.67 7.27 294.63 274.67 7.27 1138.90 657.96 73.10
Other Income 2.22 2.82 -21.28 2.22 2.82 -21.28 11.25 7.19 56.47
PBIDT 57.93 40.50 43.04 57.93 40.50 43.04 201.23 120.98 66.33
Interest 12.55 15.52 -19.14 12.55 15.52 -19.14 52.40 59.48 -11.90
PBDT 45.38 24.98 81.67 45.38 24.98 81.67 148.83 61.50 142.00
Depreciation 13.10 11.91 9.99 13.10 11.91 9.99 52.19 46.85 11.40
PBT 32.28 13.07 146.98 32.28 13.07 146.98 96.64 14.65 559.66
TAX 9.59 3.50 174.00 9.59 3.50 174.00 28.76 2.57 1019.07
Deferred Tax 4.20 1.32 218.18 4.20 1.32 218.18 13.09 0.77 1600.00
PAT 22.69 9.57 137.10 22.69 9.57 137.10 67.88 12.08 461.92
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 19.66 14.74 33.35 19.66 14.74 33.35 17.67 18.39 -3.91
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..